➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: October 22, 2021

DrugPatentWatch Database Preview

Litigation Details for Unimed Pharmaceuticals LLC v. Perrigo Company (D. Del. 2013)

Email this page to a colleague

« Back to Dashboard

Unimed Pharmaceuticals LLC v. Perrigo Company (D. Del. 2013)

Docket ⤷  Free Forever Trial Date Filed 2013-02-15
Court District Court, D. Delaware Date Terminated 2015-05-05
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Patents 6,503,894; 8,466,136; 8,466,137; 8,466,138; 8,486,925; 8,729,057; 8,741,881; 8,754,070; 8,759,329
Attorneys John C. Phillips , Jr.
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Unimed Pharmaceuticals LLC v. Perrigo Company
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Unimed Pharmaceuticals LLC v. Perrigo Company (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2014-08-20 165 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,503,894 B1; 8,466,136 B2; 8,466,137…February 2013 5 May 2015 1:13-cv-00236 830 Patent None District Court, D. Delaware External link to document
2014-08-20 166 notice re Patent No. 6,503,894. Date of Expiration of Patent: August 30, 2020 for Patent No. 6,503,894; October… Amended Supplemental information for patent cases involving an Abbreviated New Drug Application… Received Notice: On or about June 11, 2014 for Patent Nos. 8,466,136; 8,466,138; 8,466,138; and 8,486,9258,486,925; On or about August 12, 2014 for Patent Nos. 8,729,057; 8,741,881; 8,754,070; and 8,759,329; plaintiffs…October 12, 2026 for all other patents.Thirty Month Stay Deadline: 12/11/2016. (Kraftschik, Stephen) (Entered External link to document
2014-08-25 167 ; U.S. Patent No. 8,466,138; U.S. Patent No. 8,486,925; and U.S. Patent No. 6,503,894), ifand… (RGA) (U.S. Patent No. 8,729,057; U.S. Patent No. 8,741,881; U.S. Patent No. 8,754,070; and…terms for patents identified in 14-985 (RGA) (U.S. Patent No. 8,466,136; U.S. Patent No. 8,466,137… U.S. Patent No. 8,759,329 (referred to herein collectively as "New Patents")) …claims for New Patents and for Perrigo's ANDA No. 205781 for already-asserted patents per Default External link to document
0000-00-00 168 List of Claim Terms/Phrases to be Construed re 8,729,057; 8,741,881; and 8,759,329 filed by Watson Laboratories…February 2013 5 May 2015 1:13-cv-00236 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.